Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01478074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02283190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00840684. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory
ClinicalTrials.gov study NCT03969446. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02070458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
ClinicalTrials.gov study NCT05736978. IPD Sharing: NO. Countries: 1. Publications: 0.
LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01041040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
ClinicalTrials.gov study NCT06456463. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
ClinicalTrials.gov study NCT03699384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov study NCT03921047. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05330364. IPD Sharing: NO. Countries: 1. Publications: 0.
A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06182592. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02859948. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04415008. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04826523. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
ClinicalTrials.gov study NCT01819792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00039091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07028073. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06367673. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04443751. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.